AmirAli Talasaz

New Capabilities

Leading R&D on the Smart Platform behind the new test

For most patients with advanced cancer, picking the right targeted drug still starts with a tissue biopsy. On May 20, the FDA approved a blood test that reads 100 times more of the tumor's DNA than the previous version.

Updated May 20